E Tanis1, J W Spliethoff2, D J Evers2, G C Langhout2, P Snaebjornsson3, W Prevoo4, B H W Hendriks5, T J M Ruers6. 1. Department of Surgery, Netherlands Cancer Institute, P.O. Box 90203, 1006BE, Amsterdam, The Netherlands. Electronic address: ErikTanis@gmail.com. 2. Department of Surgery, Netherlands Cancer Institute, P.O. Box 90203, 1006BE, Amsterdam, The Netherlands. 3. Department of Pathology, Netherlands Cancer Institute, P.O. Box 90203, 1006BE, Amsterdam, The Netherlands. 4. Department of Radiology, Netherlands Cancer Institute, P.O. Box 90203, 1006BE, Amsterdam, The Netherlands. 5. Minimally Invasive Healthcare Department, Philips Research, High Tech Campus 34, 5656AE, Eindhoven, The Netherlands. 6. Department of Surgery, Netherlands Cancer Institute, P.O. Box 90203, 1006BE, Amsterdam, The Netherlands; MIRA Institute, University of Twente, P.O. Box 217, 7500AE, Enschede, The Netherlands.
Abstract
BACKGROUND: The success of radiofrequency (RF) ablation is limited by the inability to assess thermal tissue damage achieved during or immediately after the procedure. The goal of this proof-of-principle study was to investigate whether diffuse reflectance (DR) spectroscopy during and after RF ablation of liver tumours could aid in detecting complete tissue ablation. MATERIAL AND METHODS: DR spectra were acquired in vivo in eight patients undergoing RF ablation for unresectable colorectal liver metastases, using a disposable spectroscopy needle. Intraoperative ultrasound imaging was used for accurate positioning of the RF electrode and the spectroscopy needle. Spectral changes were quantified and correlated to tissue histopathology and follow-up CT imaging. RESULTS: For the lesions in which ablation was monitored by DR spectroscopy (N = 8), median tumour size was 1.6 cm (range 0.8-3.3 cm). We found an excellent correlation (97-99%) between thermal damage suggested by spectral changes and histology. DR spectroscopy allowed discrimination between non-ablated and ablated tissue, regardless whether the needle was placed in tumour tissue or in surrounding liver tissue. Additional measurements performed continuously during ablation confirmed that the magnitude of spectral change correlates with the histochemical degree of thermal damage. CONCLUSIONS: Diffuse reflectance spectroscopy allows accurate quantification of thermal tissue damage during and after RF ablation. Real-time feedback by DR spectroscopy could improve the accuracy and quality of the RF procedures by lowering incomplete ablation rates.
BACKGROUND: The success of radiofrequency (RF) ablation is limited by the inability to assess thermal tissue damage achieved during or immediately after the procedure. The goal of this proof-of-principle study was to investigate whether diffuse reflectance (DR) spectroscopy during and after RF ablation of liver tumours could aid in detecting complete tissue ablation. MATERIAL AND METHODS: DR spectra were acquired in vivo in eight patients undergoing RF ablation for unresectable colorectal liver metastases, using a disposable spectroscopy needle. Intraoperative ultrasound imaging was used for accurate positioning of the RF electrode and the spectroscopy needle. Spectral changes were quantified and correlated to tissue histopathology and follow-up CT imaging. RESULTS: For the lesions in which ablation was monitored by DR spectroscopy (N = 8), median tumour size was 1.6 cm (range 0.8-3.3 cm). We found an excellent correlation (97-99%) between thermal damage suggested by spectral changes and histology. DR spectroscopy allowed discrimination between non-ablated and ablated tissue, regardless whether the needle was placed in tumour tissue or in surrounding liver tissue. Additional measurements performed continuously during ablation confirmed that the magnitude of spectral change correlates with the histochemical degree of thermal damage. CONCLUSIONS: Diffuse reflectance spectroscopy allows accurate quantification of thermal tissue damage during and after RF ablation. Real-time feedback by DR spectroscopy could improve the accuracy and quality of the RF procedures by lowering incomplete ablation rates.
Authors: Vlasios S Sotirchos; Sho Fujisawa; Efsevia Vakiani; Stephen B Solomon; Katia O Manova-Todorova; Constantinos T Sofocleous Journal: Ann Surg Oncol Date: 2019-03-04 Impact factor: 5.344
Authors: Francois H Cornelis; Elena N Petre; Efsevia Vakiani; David Klimstra; Jeremy C Durack; Mithat Gonen; Joseph Osborne; Stephen B Solomon; Constantinos T Sofocleous Journal: J Nucl Med Date: 2018-02-09 Impact factor: 10.057
Authors: Gustav Burström; Akash Swamy; Jarich W Spliethoff; Christian Reich; Drazenko Babic; Benno H W Hendriks; Halldor Skulason; Oscar Persson; Adrian Elmi Terander; Erik Edström Journal: Biomed Opt Express Date: 2019-10-24 Impact factor: 3.732
Authors: Elisabeth J M Baltussen; Henricus J C M Sterenborg; Theo J M Ruers; Behdad Dashtbozorg Journal: Biomed Opt Express Date: 2019-11-05 Impact factor: 3.732
Authors: Timothy J Ziemlewicz; J Louis Hinshaw; Meghan G Lubner; Emily A Knott; Bridgett J Willey; Fred T Lee; Christopher L Brace Journal: Int J Hyperthermia Date: 2020 Impact factor: 3.914
Authors: Simon Skyrman; Gustav Burström; Oskar Aspegren; Drazenko Babic; Gerald Lucassen; Erik Edström; Fabian Arnberg; Marcus Ohlsson; Manfred Mueller; Adrian Elmi-Terander; Tommy Andersson Journal: Biomed Opt Express Date: 2022-05-10 Impact factor: 3.562
Authors: Nikiforos Vasiniotis Kamarinos; Efsevia Vakiani; Sho Fujisawa; Mithat Gonen; Ning Fan; Yevgeniy Romin; Richard K G Do; Etay Ziv; Joseph P Erinjeri; Elena N Petre; Vlasios S Sotirchos; Juan C Camacho; Stephen B Solomon; Katia Manova-Todorova; Constantinos T Sofocleous Journal: J Vasc Interv Radiol Date: 2021-11-17 Impact factor: 3.682